GSE248770 STIM1 knockout Hep 3B2.1-7 Sorafenib 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE248770_STIM1 knockout_Hep 3B2.1-7_Sorafenib_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE248770_STIM1 knockout_Hep 3B2.1-7_Sorafenib_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE248770_STIM1 knockout_Hep 3B2.1-7_Sorafenib_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE248770_STIM1 knockout_Hep 3B2.1-7_Sorafenib_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

microtubule associated protein 7

Gene

GNAS complex locus

Gene

aquaporin 3 (Gill blood group)

Gene

clusterin

Gene

activating transcription factor 3

Gene

inhibitor of DNA binding 1

Gene

selenoprotein P

Gene

argininosuccinate synthase 1

Gene

transmembrane 4 L six family member 1

Gene

3-hydroxy-3-methylglutaryl-CoA synthase 1

  • Gene

    microtubule associated protein 7


  • Gene

    GNAS complex locus


  • Gene

    aquaporin 3 (Gill blood group)



  • Gene

    activating transcription factor 3


  • Gene

    inhibitor of DNA binding 1



  • Gene

    argininosuccinate synthase 1


  • Gene

    transmembrane 4 L six family member 1


  • Gene

    3-hydroxy-3-methylglutaryl-CoA synthase 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.